Magnus Meditourism Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 23-10-2024
- Paid Up Capital ₹ 1.31 M
as on 23-10-2024
- Company Age 9 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 23-10-2024
- Revenue 137.69%
(FY 2023)
- Profit 214.93%
(FY 2023)
- Ebitda 100.08%
(FY 2023)
- Net Worth 221.02%
(FY 2023)
- Total Assets 20.94%
(FY 2023)
About Magnus Meditourism
The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.31 M.
The company currently has active open charges totaling ₹5.00 M.
Bhavya Vora and Mihir Vora serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC271913
- Company No.
271913
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
What products or services does Magnus Meditourism Private Limited offer?
Magnus Meditourism Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Magnus Meditourism?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavya Vora  | Director | 11-Jan-2016 | Current |
| Mihir Vora | Director | 11-Jan-2016 | Current |
Financial Performance of Magnus Meditourism.
Magnus Meditourism Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 137.69% increase. The company also saw a substantial improvement in profitability, with a 214.93% increase in profit. The company's net worth Soared by an impressive increase of 221.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magnus Meditourism?
In 2023, Magnus Meditourism had a promoter holding of 76.16% and a public holding of 23.84%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Simplify Medtech Private LimitedActive 3 years 2 monthsBhavya Vora and Mihir Vora are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Jun 2017 | ₹5.00 M | Open |
How Many Employees Work at Magnus Meditourism?
Unlock and access historical data on people associated with Magnus Meditourism, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magnus Meditourism, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnus Meditourism's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
